Supporting Statement B For:
Multidisciplinary Treatment Planning (MTP) within the
National Cancer Institute (NCI) Community Cancer Centers Program
December 27, 2013
Irene Prabhu Das
Division of Cancer Control & Population Sciences
Applied Research Program, Outcomes Research Branch
National Cancer Institute
9609 Medical Center Drive
Room 3E-518 MSC 9704
Bethesda, MD 20892-0704
Telephone: 240-276-6799
Fax: 240-276-7906
E-mail: [email protected]
Table of Contents
B. Collection of Information employing statistical methods 1
B.1 Respondent Universe and Sampling Methods 1
B.2. Procedures for the Collection of Information 1
B.3 Methods to Maximize Response Rates and Deal with Nonresponse 4
B.4 Test of Procedures or Methods to be Undertaken 5
B.5 Individuals Consulted on Statistical Aspects and Individuals Collecting
and/or Analyzing Data 5
List of Attachments
List of Attachments
Attachment 1: Background Information & References/Citations
Attachment 2: Consent, Screenshots and PDF1of the Surveys
2Ai: Head and Neck Survey Screenshots
2Aii: Head and Neck Survey PDF Sent with Introduction
2Bi: Breast Survey Screenshots
2Bii: Breast Survey PDF Sent with Introduction
2Ci: Lung Survey Screenshots
2Cii: Lung Survey PDF Sent with Introduction
Attachment 3: Tumor Site Assignment
Attachment 4: Introduction and Reminder Emails
Attachment 5: List of Consultants
Attachment 6: Privacy Act Memo
Attachment 7: OHSR Approval Letter
Attachment 8: Telephone Reminder Script
The aim of this organizational survey is to understand how NCI Community Cancer Centers Program (NCCCP) hospitals define, organize and implement multidisciplinary treatment planning (MTP), which is the fundamental aspect of multidisciplinary care. All 21 NCCCP hospitals will comprise the universe of respondent sites for this study and each hospital will be assigned to respond for one of three tumor sites (Breast, Lung, Head and Neck). Therefore, no sampling of hospitals or tumor sites will be needed.
The NCCCP has developed a focus around multidisciplinary care within the Quality of Care component. All 21 hospitals assess their own development of multidisciplinary care programs, which involves increasing the proportion of cases presented for prospective treatment planning. Given the program focus, we anticipate that 85% of the 21 NCCCP hospitals will participate in the survey.
Tumor sites were assigned using a step-wise approach using two criteria: MTP meetings reported and volume of cases for the three tumor sites (breast, lung, and head/neck). First, we reviewed program quarterly reports for all NCCCP facilities over two quarters (January – June 2012) to identify the number of cases presented at an MTP meeting for each tumor site. Secondly, we tabulated the NCCCP facilities with highest case volumes for each tumor. Finally, to assure that NCCCP facilities were distributed as evenly as possible among the three tumor sites, we selectively assigned each facility a tumor site based on highest case volume for that facility. The final assignments are as follows: Breast (7 hospitals), Lung (8 hospitals), and Head/Neck (6 hospitals) (Attachment 3).
The link to the online survey is unique to each NCCCP hospital based on the assigned tumor site.
Data Collection Procedures:
The NCCCP Principal Investigator (PI) and the Quality of Care (QoC) Subcommittee Lead will be contacted via e-mail (Attachment 4) to participate in this survey. All NCCCP PI’s and QoC Leads will be informed during their regularly scheduled calls at least one month prior to survey administration. A cover e-mail along with a link to the online survey and a PDF version of the survey will be sent to the QoC Leads with a copy to the NCCCP PI at each site. The Quality of Care leads will be asked to either complete the survey or to coordinate the completion of the survey by an appropriate respondent(s). Since this survey is intended to characterize MTP in NCCCP hospitals, data collected will reflect the organization’s description of their MTP and operations, and not an individual perspective. Hence, participants will be encouraged to consult with colleagues at their facility, regardless of whether they are involved with the NCCCP or not to improve the accuracy and completeness of their responses.
The consent form (Attachment 2) is included in the online survey explaining participants’ rights with regard to the study. Both the cover e-mail (Attachment 4) as well as the survey instrument (Attachment 2) will explicitly inform the site that they are not required to participate in the study as a NCCCP deliverable. Participants’ consent will be considered implied through the completion of the electronic survey. The survey will be completed using Survey Monkey, an online survey software and questionnaire tool (www.surveymonkey.com). The web link, the online survey instrument, and all files submitted through the Survey Monkey server are secured by encryption.
The survey will be in the field for eight weeks. Three reminders will be sent to only those NCCCP hospitals that have not completed the online survey at that time. Once the online data collection ends, the data will be converted to an Excel file and then to an analytic format using SAS or STATA. Open text responses to five questions and for the “Other” options will be independently coded and categorized through an iterative process by each member of the research team. A consensus approach will be used to finalize the categories for analysis. Both the survey data and respective program characteristics will be linked to create the final dataset. There are three questions pertaining to the organization’s policies, procedures, guidelines and evaluation documents (Attachment 2: # 9, 17, & 62). If the NCCCP hospitals agree to share them, a member of the NIH research team will follow-up with them via e-mail to obtain the documents (Attachment 4). These documents will be examined using qualitative content analysis to supplement MTP characterization at NCCCP hospitals. Facility names and other identifying information on NCCCP documents shared will be redacted. The site ID codes assigned to the survey will be used on the redacted documents. All NCCCP data will be linked by the site ID code. The data from this qualitative examination will be incorporated into the final analytic dataset. This will be a one-time data collection. Additional procedures will be established to assure data quality control for collection and analysis.
Up to three reminders will be sent to those NCCCP hospitals that have not responded by a given time during the survey period. The first two reminders will be sent by e-mail (Attachment 4) to the NCCCP Principal Investigators and the QoC Leads three weeks after the initial contact (1st reminder) and then two weeks before the end of the survey period (2nd reminder). The third reminder will consist of a telephone call by a member of the research team to the NCCCP PI one week before the end of data collection.
The number of survey responses received by the end of the data collection period will be divided by the total number of NCCCP sites (n=21) to calculate the response rate. We are hopeful that all of the 21 hospitals will participate given their experience in developing multidisciplinary care as a program priority. However, as the survey is voluntary, we expect that a few hospitals may choose not to participate, and therefore, expect a minimum response rate of 85%.
Non-response weighting Adjustment
This MTP survey attempts to obtain responses from all 21 NCCCP funded hospitals. If the response rate is less than 100%, weighting will be used to account for hospitals that do not participate in the MTP survey. Non-response weighting adjustments will be carried out by tumor sites (Breast, Lung, Head and Neck) once data collection is complete. Because the survey will be a census of all NCCCP funded hospitals, all hospitals will be sampled with certainty and the non-response adjustment will be the only weight that needs to be applied to produce estimates of the full population. The non-response adjustment weight will be the ratio of the number of eligible hospitals in the sample (which will also be the number in the population) to the number of responding eligible hospitals for each of the three tumor sites.
In 2010, the National Cancer Institute (NCI) provided the technical expertise to the American College of Surgeons’ Commission on Cancer (CoC) to develop a survey on multidisciplinary treatment planning. NCCCP clinicians provided expert review on the survey items very early in the development of the instrument. The instrument was cognitively tested among CoC-accredited facilities. OMB approved pre-testing clearance for the cognitive testing (OMB No.: 0925-0589-07; Expiration Date: 5/31/2011). The CoC administered the survey to their accredited facilities in October 2012.
The questions on the CoC MTP survey formed the basis for the questions for the NCCCP MTP survey and the preliminary analyses of the CoC MTP survey informed the revision of some items for the proposed survey data collection. The CoC survey results revealed that certain questions may not have been clear or reflected facilities’ implementation of MTP.
Several individuals were consulted and were integral to the development of the research plan, the revision of survey questions, and the analysis plan. Some of the same individuals will be involved with the analysis once the data are collected (Attachment 5).
1 PDF of the survey will be sent in advance, along with the email invitation so that the hospital staff can review and collaborate on responding to the questions. The screenshots are also supplied to demonstrate what the hospital staff will see when they enter their responses on-line.
File Type | application/vnd.openxmlformats-officedocument.wordprocessingml.document |
File Title | TABLE OF CONTENTS |
Author | Vivian Horovitch-Kelley |
File Modified | 0000-00-00 |
File Created | 2021-01-28 |